drugset / Trial / NCT05041946

Patient Controlled Methylphenidate for Cancer Related Fatigue: A Double Blind, Randomized, Placebo Controlled Trial

NCT05041946

Phase 3 Completed 112 enrolled M.D. Anderson Cancer Center
RandomizedSingle-groupDouble-blindTreatment

Summary

To determine the effectiveness of patient controlled methylphenidate as compared to placebo for the management of cancer related fatigue as determined by the Functional Assessment of Chronic Illness Therapy (FACIT)-F Fatigue score.

Timeline

Start
2003-07-16
Primary completion
2004-12-15
Completion
2021-11-19

Drugs

EvaluationDrugModalityDoseRoute
Subject Methylphenidate Small molecule Oral

Indications